Rofim key facts
as of Oct 2026- Operator of a telemedicine platform intended for sharing clinical and patient-related data between doctors, clinics, and patients.
- Rofim is valued at approximately $24.3M as of Oct 2026 (last reported valuation).
- It has raised $16.7M; the latest was Later Stage VC ($10.9M) in Jul 2025.
- Notable investors include Google for Startups, Région Sud Investissement, Banque des Territoires, Axeltim, Buena Vista Capital — 14 tracked in total.
- Status: Privately Held (backing).
Rofim's last reported valuation, Jul 2025. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch Rofim: the Monday email on marks, rounds and moves
Rofim funding rounds
No funding rounds for Rofim are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Rofim
14+Rofim valuation
Rofim's last reported valuation was $24.3 million in Jul 2025. No priced round, secondary trade or fund mark has surfaced since.
Rofim investors
14 investors are on record for Rofim, including Google for Startups, Région Sud Investissement, Banque des Territoires and Axeltim.
About Rofim
Operator of a telemedicine platform intended for sharing clinical and patient-related data between doctors, clinics, and patients. The company's platform provides access to clinical description data and medical imaging in real-time, lets users connect to doctors and request health-related information, and features secure exchange and file-sharing tools, enabling doctors to organize and communicate health data and offer medical consultation to patients, anytime, and from any place.
- Sector
- Healthcare
- HQ
- Marseille, France
- Founded
- 2018
- Employees
- 30
- Website
- rofim.doctor/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.